122 related articles for article (PubMed ID: 35202050)
1. Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children.
Benki-Nugent SF; Yunusa R; Mueni A; Laboso T; Tamasha N; Njuguna I; Gómez L; Wamalwa DC; Tapia K; Maleche-Obimbo E; Bangirana P; Boivin MJ; John-Stewart GC
J Acquir Immune Defic Syndr; 2022 Apr; 89(4):441-447. PubMed ID: 35202050
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
Bulterys MA; Njuguna I; King'e M; Chebet D; Moraa H; Gomez L; Onyango A; Malavi K; Nzia G; Chege M; Neary J; Wagner AD; Lawley KA; Wamalwa D; Benki-Nugent S; John-Stewart G
J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174
[TBL] [Abstract][Full Text] [Related]
3. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
Green F; du Plooy C; Rehman AM; Nhapi RT; Lake MT; Barnett W; Hoffman N; Zar HJ; Donald KA; Stein DJ; Wedderburn CJ
PLoS One; 2024; 19(4):e0297471. PubMed ID: 38598467
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive outcomes of children exposed to and living with HIV aged 3-5 years in Kilifi, Kenya.
Chongwo EJ; Wedderburn CJ; Nyongesa MK; Sigilai A; Mwangi P; Thoya J; Odhiambo R; Ngombo K; Kabunda B; Newton CR; Abubakar A
Front Reprod Health; 2023; 5():1193183. PubMed ID: 37732169
[TBL] [Abstract][Full Text] [Related]
5. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
Awadu JE; Zalwango SK; Sikorskii A; Giordani B; Bovin MJ; Musoke PM; Ezeamama AE
Medicine (Baltimore); 2023 Jan; 102(4):e32677. PubMed ID: 36705393
[TBL] [Abstract][Full Text] [Related]
6. Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
Awadu JE; Sikorskii A; Zalwango S; Coventry A; Giordani B; Ezeamama AE
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329408
[TBL] [Abstract][Full Text] [Related]
7. Higher Hospitalization Rates in Children Born HIV-exposed Uninfected in British Columbia, Canada, Between 1990 and 2012.
Li SNJ; Albert A; Piske M; Janssen PA; Alimenti A; Jesson J; Côté HCF; Sauvé L
Pediatr Infect Dis J; 2022 Feb; 41(2):124-130. PubMed ID: 34711783
[TBL] [Abstract][Full Text] [Related]
8. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
[TBL] [Abstract][Full Text] [Related]
10. In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda.
Coventry A; Sikorskii A; Zalwango SK; Familiar-Lopez I; Cardino VN; Giordani B; Ezeamama AE
Res Nurs Health; 2024 Apr; 47(2):195-207. PubMed ID: 38031814
[TBL] [Abstract][Full Text] [Related]
11. Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe.
Ntozini R; Chandna J; Evans C; Chasekwa B; Majo FD; Kandawasvika G; Tavengwa NV; Mutasa B; Mutasa K; Moulton LH; Humphrey JH; Gladstone MJ; Prendergast AJ;
J Int AIDS Soc; 2020 May; 23(5):e25456. PubMed ID: 32386127
[TBL] [Abstract][Full Text] [Related]
12. Attention and neurodevelopment in young children who are HIV-exposed uninfected.
Young JM; Chen V; Bitnun A; Read SE; Smith ML
AIDS Care; 2024 Jan; 36(1):26-35. PubMed ID: 37523616
[No Abstract] [Full Text] [Related]
13. Cognitive and Language Development at Age 4-6 Years in Children HIV-Exposed But Uninfected Compared to Those HIV-Unexposed and to Children Living With HIV.
Gruver RS; Mall S; Kvalsvig JD; Knox JR; Mellins CA; Desmond C; Kauchali S; Arpadi SM; Taylor M; Davidson LL
New Dir Child Adolesc Dev; 2020 May; 2020(171):39-54. PubMed ID: 32618410
[TBL] [Abstract][Full Text] [Related]
14. Early Antiretroviral Therapy Reduces Severity but Does Not Eliminate Neurodevelopmental Compromise in Children With HIV.
Benki-Nugent S; Tamasha N; Mueni A; Laboso T; Wamalwa DC; Njuguna I; Gómez L; Tapia K; Bangirana P; Maleche-Obimbo E; Boivin MJ; John-Stewart GC
J Acquir Immune Defic Syndr; 2023 May; 93(1):7-14. PubMed ID: 36693138
[TBL] [Abstract][Full Text] [Related]
15. Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: a longitudinal investigation.
van Wyhe KS; Laughton B; Cotton MF; Meintjes EM; van der Kouwe AJ; Boivin MJ; Kidd M; Thomas KG
J Int AIDS Soc; 2021 Jul; 24(7):e25734. PubMed ID: 34259393
[TBL] [Abstract][Full Text] [Related]
16. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
17. Children of a syndemic: co-occurring and mutually reinforcing adverse child health exposures in a prospective cohort of HIV-affected mother-infant dyads in Cape Town, South Africa.
le Roux SM; Abrams EJ; Zerbe A; Phillips TK; Myer L
J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26152. PubMed ID: 37909170
[TBL] [Abstract][Full Text] [Related]
18. Neurological development of children who are HIV-exposed and uninfected.
Toledo G; Côté HCF; Adler C; Thorne C; Goetghebuer T
Dev Med Child Neurol; 2021 Oct; 63(10):1161-1170. PubMed ID: 33987826
[TBL] [Abstract][Full Text] [Related]
19. Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study.
Ramokolo V; Kuhn L; Lombard C; Jackson D; Goga AE
BMC Infect Dis; 2022 Dec; 22(1):908. PubMed ID: 36474212
[TBL] [Abstract][Full Text] [Related]
20. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
